WO2014030992A3 - Composición antiséptica, seborreguladora y exfoliante para tratar o prevenir el acné - Google Patents

Composición antiséptica, seborreguladora y exfoliante para tratar o prevenir el acné Download PDF

Info

Publication number
WO2014030992A3
WO2014030992A3 PCT/MX2013/000099 MX2013000099W WO2014030992A3 WO 2014030992 A3 WO2014030992 A3 WO 2014030992A3 MX 2013000099 W MX2013000099 W MX 2013000099W WO 2014030992 A3 WO2014030992 A3 WO 2014030992A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
preventing
acne
exfolitating
seboregulating
Prior art date
Application number
PCT/MX2013/000099
Other languages
English (en)
French (fr)
Other versions
WO2014030992A2 (es
Inventor
José Agustín Rogelio MAGAÑA CASTRO
Laura VÁZQUEZ CARVANTES
Pedro PEÑA SANTOYO
Original Assignee
Grupo Medifarma, S.A. De C.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grupo Medifarma, S.A. De C.V. filed Critical Grupo Medifarma, S.A. De C.V.
Priority to US14/421,616 priority Critical patent/US20150231098A1/en
Priority to CA2882392A priority patent/CA2882392C/en
Publication of WO2014030992A2 publication Critical patent/WO2014030992A2/es
Publication of WO2014030992A3 publication Critical patent/WO2014030992A3/es
Priority to US16/008,210 priority patent/US20180353448A1/en
Priority to US16/371,670 priority patent/US10792258B2/en
Priority to US17/063,458 priority patent/US20210093593A1/en
Priority to US17/855,072 priority patent/US20230165819A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invención se relaciona con una composición hidrosoluble antimicrobiana, exfoliante y seborreguladora que comprende una combinación de Dialil Óxido de Disulfuro Modificado (ODD-M) y ácido alfa hidroxietanóico (ácido glicólico) que actúa eliminando las bacterias que afectan la piel incluyendo aquellas causantes del acné, dicha composición también proporciona una limpieza profunda, una acción exfoliante, disminuye la cohesión epidérmica que facilita el recambio celular, previniendo la ocurrencia de diversas formas de acné en la piel y adicionalmente produce efectos seborreguladores al evitar el taponamiento de las glándulas sebáceas.
PCT/MX2013/000099 2012-08-23 2013-08-22 Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné WO2014030992A2 (es)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US14/421,616 US20150231098A1 (en) 2012-08-23 2013-08-22 Antiseptic, antiseborrheic, exfoliating composition for getting rid of or preventing acne
CA2882392A CA2882392C (en) 2012-08-23 2013-08-22 Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
US16/008,210 US20180353448A1 (en) 2012-08-23 2018-06-14 Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
US16/371,670 US10792258B2 (en) 2012-08-23 2019-04-01 Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
US17/063,458 US20210093593A1 (en) 2012-08-23 2020-10-05 Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
US17/855,072 US20230165819A1 (en) 2012-08-23 2022-06-30 Antiseptic, antiseborrheic, exfoliating composition to remove or prevent acne

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXMX/A/2012/009806 2012-08-23
MX2012009806A MX356551B (es) 2012-08-23 2012-08-23 Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US14/421,616 A-371-Of-International US20150231098A1 (en) 2012-08-23 2013-08-22 Antiseptic, antiseborrheic, exfoliating composition for getting rid of or preventing acne
US16/008,210 Continuation US20180353448A1 (en) 2012-08-23 2018-06-14 Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne

Publications (2)

Publication Number Publication Date
WO2014030992A2 WO2014030992A2 (es) 2014-02-27
WO2014030992A3 true WO2014030992A3 (es) 2014-10-23

Family

ID=49230828

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MX2013/000099 WO2014030992A2 (es) 2012-08-23 2013-08-22 Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné

Country Status (7)

Country Link
US (5) US20150231098A1 (es)
AR (1) AR092199A1 (es)
CA (1) CA2882392C (es)
MX (1) MX356551B (es)
TW (1) TW201416071A (es)
UY (1) UY34985A (es)
WO (1) WO2014030992A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
MX356551B (es) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
MX366086B (es) 2017-08-15 2019-06-27 Cell Therapy And Tech S A De C V Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel.
CN111763630A (zh) * 2019-03-27 2020-10-13 深圳微健康基因科技有限公司 表皮葡萄球菌及其用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105782A (en) * 1975-03-07 1978-08-08 Yu Ruey J Treatment of acne and dandruff
US20060115503A1 (en) * 2004-11-30 2006-06-01 Goyal Muna C Composition, system and method for treatment of skin
WO2008107873A1 (en) * 2007-03-02 2008-09-12 Yeda Res & Dev Mercaptopurine derivatives as anticancer agents

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376118A (en) 1980-10-06 1983-03-08 Miles Laboratories, Inc. Stable nonaqueous solution of tetracycline salt
US5009895A (en) 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
CN1104899C (zh) 1995-12-21 2003-04-09 美国辉瑞有限公司 可注射喹诺酮制剂
US5958420A (en) 1997-03-13 1999-09-28 Nortrade Medical, Inc. Treatment of burns, cuts, and abrasions of the skin
US6365131B1 (en) 1997-10-31 2002-04-02 J. B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic
GB9810949D0 (en) * 1998-05-22 1998-07-22 Hewlett Healthcare Limited Formulation
US6492395B1 (en) 1998-09-18 2002-12-10 Mepha Ag Topical formulation of alkyl-, phenyl-pyridone
IN191090B (es) 2000-08-29 2003-09-20 Ranbanx Lab Ltd
WO2002060446A1 (en) 2001-01-29 2002-08-08 Shionogi & Co., Ltd. Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
WO2004073713A1 (ja) 2003-02-21 2004-09-02 Shionogi & Co., Ltd. ピルフェニドンのゲル剤
WO2005062739A2 (en) * 2003-05-23 2005-07-14 Ott David M S-allylmercaptocysteine prodrugs and methods of treatment
US20060051339A1 (en) * 2004-09-08 2006-03-09 Sivak Hannah N Composition for treatment of oily skin and acne prevention and methods of making and using same
NZ591443A (en) 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients
AU2008265595B2 (en) 2007-06-20 2014-12-04 PureTech LYT 100 Inc. Substituted N-Aryl pyridinones as fibrotic inhibitors
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
CN101972236A (zh) 2010-10-13 2011-02-16 北京诚创康韵医药科技有限公司 一种含吡非尼酮的缓释制剂
US9241921B2 (en) * 2011-05-02 2016-01-26 Pankaj Modi Photosensitizer composition for treating skin disorders
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
MX356551B (es) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
MX352342B (es) 2013-07-12 2017-11-22 Moleculas Naturales S A De C V Star Un procedimiento para fabricar un complejo mejorado de cloruro de bencetonio-dialil oxido de disulfuro modificado, el complejo obtenido y sus usos.
MX364040B (es) 2016-11-11 2019-04-11 Cell Therapy And Tech S A De C V Uso farmacéutico de una composición que contiene pirfenidona de liberación prolongada (pfd-lp) para la reversión y tratamiento de la esteatohepatitis humana (nafld/nash).

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105782A (en) * 1975-03-07 1978-08-08 Yu Ruey J Treatment of acne and dandruff
US20060115503A1 (en) * 2004-11-30 2006-06-01 Goyal Muna C Composition, system and method for treatment of skin
WO2008107873A1 (en) * 2007-03-02 2008-09-12 Yeda Res & Dev Mercaptopurine derivatives as anticancer agents

Also Published As

Publication number Publication date
US10792258B2 (en) 2020-10-06
CA2882392C (en) 2021-10-12
TW201416071A (zh) 2014-05-01
US20150231098A1 (en) 2015-08-20
MX356551B (es) 2018-06-04
US20230165819A1 (en) 2023-06-01
WO2014030992A2 (es) 2014-02-27
CA2882392A1 (en) 2014-02-27
US20190290606A1 (en) 2019-09-26
AR092199A1 (es) 2015-04-08
MX2012009806A (es) 2014-02-24
UY34985A (es) 2014-02-28
US20180353448A1 (en) 2018-12-13
US20210093593A1 (en) 2021-04-01

Similar Documents

Publication Publication Date Title
WO2014030992A3 (es) Composición antiséptica, seborreguladora y exfoliante para tratar o prevenir el acné
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
EP2418945A4 (en) Mineral salt-sulfuric acid compositions and methods for their use
MX2014011181A (es) Microemulsiones basadas en ciclodextrina y usos dermatologicos de las mismas.
MX353942B (es) Sistemas para el cuidado de la piel después del procedimiento, composiciones y métodos de uso de los mismos.
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
MX2011006381A (es) Uso de una composicion espumable esencialmente libre de ingredientes con actividad farmaceutica para el tratamiento de la piel humana.
PH12015501887B1 (en) Novel bacteriophage and antibacterial composition comprising the same
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
NZ707113A (en) Compositions comprising peroxy acid
PH12014502154A1 (en) Semi-solid topical composition which contains pirfenidone and modified diallyl disulphide oxide (m-ddo) for eliminating or preventing acne
PH12015501045A1 (en) Bpo wash gel composition
BR112012007798A2 (pt) microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas
MX2017010486A (es) Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel.
WO2012104240A3 (de) Kosmetische verwendung
MX353580B (es) Acido graso monoinsaturado para prevenir y/o tratar las imperfecciones del color de la piel.
MX2020006443A (es) Combinacion de un retinoide y un extracto de silybum marianum (l.) gaertn.
BR112015029447A2 (pt) novo composto derivados de planta do gênero quamoclit e composição contendo a mesma como ingrediente ativo para a prevenção ou tratamento da diabetes
MX2018005028A (es) Composicion para el cuidado de la piel y metodos para la misma.
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
BR112015020182A2 (pt) uso cosmético de queuina ou de um precursor ou um derivado dessa como ingrediente ativo, uso de queuina ou um precursor ou um derivado dessa como ingrediente ativo, composição cosmética e processo de tratamento cosmético para prevenir e/ou tratar sinais de envelhecimento da pele e/ou anexos cutâneos
WO2014074765A3 (en) Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing
BR112015000186A2 (pt) utilização de coceth sulfato de zinco como agente antibacteriano face o propionibacterium acnes
NZ595612A (en) Sulphurated derivatives of resorcinol for depigmentation of the skin
WO2014004178A3 (en) Compositions comprising substituted phenols and topical application thereof

Legal Events

Date Code Title Description
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 14421616

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2882392

Country of ref document: CA

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13766152

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13766152

Country of ref document: EP

Kind code of ref document: A2